C‑section, formula may disrupt ‘good’ gut bacteria in babies
Sivagnanam G1★★ Corresponding author
- 1Department of Pharmacology, Indira Gandhi Medical College and Research Institute, Kadhirkamam, Puducherry, India.
CORRESPONDENCE
Sivagnanam G
Department of Pharmacology, Indira Gandhi Medical College and Research Institute, Kadhirkamam, Puducherry, India.
Volume 4, Issue 2 · pp. 166–7 · PUBLISHED 2013 · DOI: 10.4103/0976-500X.110922
View on J Pharmacol. Pharmacother. original site ↗
ABSTRACT
Early intestinal colonization with Lactobacilli and Bifidobacteria support the concept of their ability to modify the gut microbiota with beneficial roles like reduction in the risk of cancer due to their capacity to decrease β‑glucoronidase and carcinogen levels. Thus, these agents (referred to as “probiotics”) are being tried to be employed in modern nutrition habits (with so‑called functional foods). Since they are normal residents of the microbiota in humans, whether such gut derived probiotic should be commercially employed is a matter of debate
KEYWORDS
REFERENCES
As publishedShowing references and in-text citations exactly as published.
Cite this article
SELECT FORMAT
G, S. (2013). C‑section, formula may disrupt ‘good’ gut bacteria in babies. Journal of Pharmacology and Pharmacotherapeutics, 4(2), 166–7. https://doi.org/10.4103/0976-500X.110922